The forecasted number of the top 10% cited scientific publications in biotechnology in China demonstrates a steady growth from 2024 through 2028. Starting from 688 publications in 2024, the number is expected to increase to 928 by 2028. This indicates a consistent upward trend in high-impact scientific output in the biotechnology sector. The projected compound annual growth rate (CAGR) from 2024 to 2028 is approximately 7.7%, showcasing a robust rise in prominence and contribution within the global scientific community.

Future trends to watch for include:

Continued investment in biotechnology R&D which may further boost output.
The potential impact of policy changes or strategic initiatives by the Chinese government to support science and technology.
Collaboration with international institutions that could enhance research quality and citation impact.
Technological advancements and breakthroughs driving increased research and citations.